SOURCE: Trinity Biotech UK

Trinity Biotech UK

April 22, 2009 08:00 ET

Trinity Biotech plc to Announce First Quarter 2009 Financial Results

Conference Call Scheduled for April 29, 2009 at 11:00 am EASTERN

DUBLIN, IRELAND--(Marketwire - April 22, 2009) - Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter of 2009 on Wednesday, April 29, 2009. The Company has scheduled a conference call for that same day, Wednesday, April 29, 2009, at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

   USA:             1-877-356-5706
   International:   1-706-679-3820

A simultaneous webcast of the call can be accessed at:

A replay of the call can be accessed until May 2, 2009 by dialing:

   USA:             1-800-642-1687
   International:   1-706-645-9291
   Conference ID #: 94811950

The webcast of the call will be available for 30 days at:

About Trinity Biotech plc

Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.

For further information please see the company's website:

Contact Information

  • Contact:
    Ms. Niamh Long
    Trinity Biotech plc
    Investor Relations Officer
    (353) 1 276 9800

    Joe Diaz, Joe Dorame and Robert Blum
    Lytham Partners, LLC